Oppenheimer raised the price target for the AtriCure Inc. (NASDAQ:ATRC) stock from “an Outperform” to “a Perform”. The rating was released on August 05, 2021, according to finviz. We previously noted in another research note published on December 18, 2020 by Needham that reiterated the stock to a Buy with a price target of $63 for ATRC stock. The research report from Needham has reiterated the stock to Buy, with a price target set at $53. The stock was initiated by Oppenheimer, who disclosed in a research note on April 07, 2020, to Outperform and set the price objective to $45. In their research brief published February 06, 2020, BTIG Research analysts initiated the AtriCure Inc. stock to Buy with a price target of $42.
The latest trade, Performances and Moving Averages give us the following Picture
The share price of AtriCure Inc. (NASDAQ:ATRC) dipped -0.38% to close Friday’s market session at $39.20, lower as compared to yesterday’s close. The stock price fluctuated between $38.73 and $39.99 throughout the trading session with the volume trading being 663276 shares, which represented a significant variation when compared to the three months average volume of 318.75K shares. The firm’s stock price fluctuated 9.28% within the last five trades and -7.55% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price decreased -14.60% in the last 6 months and -10.75% was subtracted to its value over the previous 3 months. ATRC stock is trading at a margin of 0.15%, -6.14% and -8.41% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
As of the close of trading, ATRC deals in the Healthcare domain. The stock is trading -42.84 percent below its 52-week high and 20.58 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is -35.97. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.
What Does AtriCure Inc.’s Profitability and Valuation Ratios Tell Us About the Stock?
With regard to the profitability of the company, the operating margin is currently at -12.90 percent and the profit margin is -14.10 percent, and the company has reported a gross margin of 74.40 percent. The profit margin, also known as the revenue ratio or gross profit ratio, is an efficiency figure used to estimate the business’s profitability by comparing net income and sales. The higher the number, the more profits are generated for the company and vice versa.
The stock’s market cap achieved a total value of $1.91 billion as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The stock has achieved an effective Price-to-Sales Ratio of 5.77 that mirrors the cost to be found for sales by the market. The firm managed a Price-to-Book ratio of 3.94, which equates the market value of a stock with its book value.
Is Insider Trading a Real Thing?
Almost all investors and traders prefer to invest in shares controlled by the management of a corporation as a management company will be more likely to run the business itself and to never conduct things against the management’s desires and will always try to do what is best for their shareholders. Currently, 1.60 percent of AtriCure Inc. shares are owned by insiders, and 99.30 percent are held by financial institutions. Doraiswamy Vinayak, the Chief Scientific Officer at AtriCure Inc. (ATRC) has sold 4,983 shares of firm on Sep 15 at a price of $45.99 against the total amount of $0.23 million. In another inside trade, Austin Tonya, Chief Human Resources Officer of AtriCure Inc. (NASDAQ:ATRC) sold 3,203 shares of the firm on May 13 for a total worth of $0.14 million at a price of $42.69. An inside trade which took place on Apr 08, Chief Human Resources Officer of AtriCure Inc. Austin Tonya sold 282 shares of firm against total price of $17368.0 at the cost of $61.59 per share.